SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    C K Brierley, T J Littlewood, A J Peniket, R Gregg, J Ward, A Clark, A Parker, R Malladi, P Medd, Impact of ABO blood group mismatch in alemtuzumab-based reduced-intensity conditioned haematopoietic SCT, Bone Marrow Transplantation, 2015, 50, 7, 931

    CrossRef

  2. 2
    Cesar Homero Gutiérrez-Aguirre, Andrés Gómez-De-León, Julio Alatorre-Ricardo, Olga Graciela Cantú-Rodríguez, Oscar González-Llano, José Carlos Jaime-Pérez, Consuelo Mancías-Guerra, Juan Antonio Flores-Jiménez, David Gómez-Almaguer, Allogeneic peripheral blood stem cell transplantation using reduced-intensity conditioning in an outpatient setting in ABO-incompatible patients: are survival and graft-versus-host disease different?, Transfusion, 2014, 54, 5
  3. 3
    Mehmet Uzunel, Darius Sairafi, Mats Remberger, Jonas Mattsson, Michael Uhlin, T-Cell Receptor Excision Circle Levels After Allogeneic Stem Cell Transplantation Are Predictive of Relapse in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome, Stem Cells and Development, 2014, 23, 14, 1559

    CrossRef

  4. 4
    Andrew C. Harris, James L. M. Ferrara, John E. Levine, Advances in predicting acute GVHD, British Journal of Haematology, 2013, 160, 3
  5. 5
    Makoto Hirokawa, Takahiro Fukuda, Kazuteru Ohashi, Michihiro Hidaka, Tatsuo Ichinohe, Koji Iwato, Heiwa Kanamori, Makoto Murata, Toru Sakura, Masahiro Imamura, Soichi Adachi, Ritsuro Suzuki, Yasuo Morishima, Hisashi Sakamaki, Efficacy and Long-Term Outcome of Treatment for Pure Red Cell Aplasia after Allogeneic Stem Cell Transplantation from Major ABO-Incompatible Donors, Biology of Blood and Marrow Transplantation, 2013, 19, 7, 1026

    CrossRef

  6. 6
    R Romee, D J Weisdorf, C Brunstein, J E Wagner, Q Cao, B R Blazar, N S Majhail, G M Vercellotti, J S Miller, M Arora, Impact of ABO-mismatch on risk of GVHD after umbilical cord blood transplantation, Bone Marrow Transplantation, 2013, 48, 8, 1046

    CrossRef

  7. 7
    A Igarashi, K Kakihana, K Haraguchi, J Aoki, T Kobayashi, Y Okuyama, K Ohashi, H Sakamaki, Anti-host isohemagglutinin production is associated with a higher risk of acute GVHD in ABO-incompatible transplantation, Bone Marrow Transplantation, 2012, 47, 10, 1356

    CrossRef

  8. 8
    Natasha Kekre, Grace Christou, Ranjeeta Mallick, Melanie Tokessy, Alan Tinmouth, Jason Tay, David S. Allan, Factors associated with the avoidance of red blood cell transfusion after hematopoietic stem cell transplantation, Transfusion, 2012, 52, 9
  9. 9
    P. Chavarin, C. DePutter, F. Boussoulade, S. Acquart, M. Vidal, C. Argaud, P. Fabrigli, O. Garraud, Inactivation/réduction des pathogènes des concentrés de plaquettes : conséquences sur l’organisation de la transfusion plaquettaire, Transfusion Clinique et Biologique, 2011, 18, 4, 472

    CrossRef

  10. 10
    S D Rowley, M L Donato, P Bhattacharyya, Red blood cell-incompatible allogeneic hematopoietic progenitor cell transplantation, Bone Marrow Transplantation, 2011, 46, 9, 1167

    CrossRef

  11. 11
    Rohini Radia, Derwood Pamphilon, Transfusion strategies in patients undergoing stem-cell transplantation, Expert Review of Hematology, 2011, 4, 2, 213

    CrossRef

  12. 12
    Sung-Eun Lee, Hee-Je Kim, Woo-Sung Min, Byung-Sik Cho, Ki-Seong Eom, Yoo-Jin Kim, Chang-Ki Min, Seok Lee, Seok-Goo Cho, Dong-Wook Kim, Jong-Wook Lee, Chong-Won Park, Chun-Choo Kim, Favorable outcomes of intravenous busulfan, fludarabine, and 400 cGy total body irradiation-based reduced-intensity conditioning allogeneic stem cell transplantation for acute myelogenous leukemia with old age and/or co-morbidities, International Journal of Hematology, 2010, 92, 2, 342

    CrossRef